- SG$55.59m
- SG$59.65m
- SG$14.70m
Annual income statement for 9R, fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 17.2 | 10.8 | 2.97 | 6.58 | 14.7 |
| Cost of Revenue | |||||
| Gross Profit | 4.98 | 3.4 | 1.27 | 3.1 | 10.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35.6 | -5.35 | 4.66 | 11.7 | 15.7 |
| Operating Profit | -18.4 | 16.1 | -1.69 | -5.16 | -0.95 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -25.4 | 15.4 | -1.75 | -5.25 | -1.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -25.5 | 15.4 | -1.97 | -5.26 | -1.98 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -26 | 15.5 | -1.79 | -5.26 | -1.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26 | 15.5 | -1.79 | -5.26 | -1.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.987 | 0.06 | -0.003 | -0.003 | -0.003 |
| Dividends per Share | |||||
| Special Dividends per Share |